This paper is in the following e-collection/theme issue:

Research Letter (75) JMIR Theme Issue: COVID-19 Special Issue (2388) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1482) Hygiene and Infection Prevention (297) Psoriasis (19)

Published on in Vol 6 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/39451, first published .
Patient Engagement With the Myderma Platform for Psoriasis During the COVID-19 Pandemic

Patient Engagement With the Myderma Platform for Psoriasis During the COVID-19 Pandemic

Patient Engagement With the Myderma Platform for Psoriasis During the COVID-19 Pandemic

Authors of this article:

Konstantinos Sfaelos1 Author Orcid Image ;   Stathis Kontodimas1 Author Orcid Image ;   Theodora Charisiadi1 Author Orcid Image ;   Nagia Chantzara2 Author Orcid Image ;   George Pesiridis1 Author Orcid Image ;   Eleftheria Tampouratzi3 Author Orcid Image
Article Authors Cited by Tweetations (4) Metrics

Konstantinos Sfaelos   1 * , PhD ;   Stathis Kontodimas   1 * , MSc ;   Theodora Charisiadi   1 * , MSc ;   Nagia Chantzara   2 * , BSc ;   George Pesiridis   1 * , MSc ;   Eleftheria Tampouratzi   3 * , MD

1 LEO Pharmaceutical Hellas, Athens, Greece

2 CORONIS Research SA, Athens, Greece

3 Dermatological Department, Tzaneio General Hospital, Piraeus, Greece

*all authors contributed equally

Corresponding Author:

  • Eleftheria Tampouratzi, MD
  • Dermatological Department
  • Tzaneio General Hospital
  • Zanni and Afentouli Avenue
  • Piraeus, 18536
  • Greece
  • Phone: 30 2132081000
  • Email: elefteria_tab@yahoo.gr